Structural and functional insights into the Leishmania donovani dynamin-1-like protein as a promising drug target

View at publisher Summarise with VIRAT
Authors: Ellen Wuyts
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Leishmaniasis remains a major neglected tropical disease requiring a multifaceted control strategy that integrates vaccination, vector control, and chemotherapy. Among these pillars, chemotherapy is indispensable for clinical management and disease control. However, increasing reports of treatment failure and the limited arsenal of effective drugs underscore the urgent need for novel antileishmanial compounds with innovative modes of action.This thesis focuses on the characterization of TCMDC-143345, a promising compound identified from the GlaxoSmithKline Leishbox, and its molecular target, the Leishmania donovani dynamin-1–like protein (LdoDLP1). Previous work established LdoDLP1 as a resistance marker for TCMDC-143345, strongly suggesting that it constitutes the compound’s molecular target. The central objective of this thesis was to deepen our understanding of the structure-function relationship of LdoDLP1 and to unravel the molecular basis underlying the antileishmanial activity of TCMDC-143345 through biochemical, structural, biophysical, and parasitological approaches. A comprehensive biophysical characterization of LdoDLP1 demonstrated its intrinsic propensity to self-assemble into higher-order oligomers, a defining feature of dynamin-related proteins (DRPs). Structure-guided mutagenesis led to the identification of a G354D/R357S double mutant with markedly altered oligomerization behavior. Analytical gel filtration, small-angle X-ray scattering, and negative-stain electron microscopy confirmed that LdoDLP1 is a bona fide DRP, lacking a canonical PH domain but containing a B-insert, thereby providing important insights into its structural organization. To elucidate the interaction between TCMDC-143345 and LdoDLP1, extensive efforts were undertaken to obtain a high-resolution structure of the protein and its complex with the compound. Although structural determination was not yet achieved, grating-coupled interferometry provided preliminary evidence supporting a direct interaction. In parallel, efforts were initiated to establish a GTPase activity assay to assess the functional impact of compound binding. As complementary tools to probe LdoDLP1 function, camelid single-domain antibodies (sdAbs) were generated. Immunization yielded 33 unique LdoDLP1-specific sdAbs, which were recombinantly produced and characterized, offering innovative reagents to further dissect LdoDLP1 self-assembly and enzymatic activity. Finally, the potential of TCMDC-143345 to induce parasite quiescence was investigated. High-dose exposure experiments followed by fluorescence-activated cell sorting demonstrated quiescent behavior, after which susceptibility was reassessed to evaluate potential shifts in drug response. Overall, LdoDLP1 appears a more challenging target than anticipated but nevertheless valuable insights into its structure, function and potential as a drug target were obtained that probes for future research.

Fields of Study & Subjects

Research on Leishmaniasis Studies Trypanosoma species research and implications Enzyme Structure and Function

Publication details

Publication date
1 January 2026
Language
EN
Document type
Thesis